Understanding how e-cigarette policies affect youth tobacco use
Evaluating the Effect of E-cigarette Policies on Youth Tobacco Use
This study looks at how different rules about e-cigarettes, like flavor bans and age limits, affect young people's use of e-cigarettes and regular tobacco, helping us understand what works best to keep kids from using these products.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Missouri-Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project ID | NIH-11086312 on NIH RePORTER |
What this research studies
This research investigates the impact of various e-cigarette policies, such as flavor bans and Tobacco-21 laws, on youth tobacco use behaviors. It aims to analyze how these regulations influence the use of e-cigarettes and combustible tobacco products among young people. By utilizing high-quality survey data and proprietary market data, the research will also explore the effects of e-cigarette taxes and purchasing behaviors, particularly in relation to out-of-state and Indian reservation purchases. The findings could provide valuable insights into effective tobacco control policies.
Who could benefit from this research
Good fit: Ideal candidates for this research include youth and young adults who use or are at risk of using e-cigarettes or other tobacco products.
Not a fit: Patients who do not use tobacco products or are not in the youth demographic may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective policies that reduce tobacco use among youth, ultimately improving public health.
How similar studies have performed: Previous research has shown that tobacco control policies can significantly impact smoking behaviors, suggesting that this approach may yield valuable insights.
Where this research is happening
Columbia, United States
- University of Missouri-Columbia — Columbia, United States (Active)
Researchers
- Principal investigator: Pesko, Michael — University of Missouri-Columbia
- Study coordinator: Pesko, Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.